Statistical Characterization of Succinoylated Dextrin Degradation Behavior in Human α-Amylase

The enhanced permeability retention effect: a new paradigm for drug targeting in infection

(2012) E. A. Azzopardi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Polymer therapeutics as nanomedicines: new perspectives

(2011) Ruth Duncan   CURRENT OPINION IN BIOTECHNOLOGY

The effect of dextrin–rhEGF on the healing of full-thickness, excisional wounds in the (db/db) diabetic mouse

(2011) Joseph T. Hardwicke et al.   JOURNAL OF CONTROLLED RELEASE

Bioresponsive Dextrin−rhEGF Conjugates:In VitroEvaluation in Models Relevant to Its Proposed Use as a Treatment for Chronic Wounds

(2010) Joseph Hardwicke et al.   MOLECULAR PHARMACEUTICS

Polymeric carriers: Preclinical safety and the regulatory implications for design and development of polymer therapeutics

(2009) Rogério Gaspar et al.   ADVANCED DRUG DELIVERY REVIEWS

Dextrin−Phospholipase A2: Synthesis and Evaluation as a Bioresponsive Anticancer Conjugate

(2009) Elaine L. Ferguson et al.   BIOMACROMOLECULES

Dextrin–trypsin and ST-HPMA–trypsin conjugates: Enzyme activity, autolysis and thermal stability

(2009) Benjaporn Treetharnmathurot et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Polymer Masked−Unmasked Protein Therapy. 1. Bioresponsive Dextrin−Trypsin and −Melanocyte Stimulating Hormone Conjugates Designed for α-Amylase Activation

(2008) Ruth Duncan et al.   BIOMACROMOLECULES

Dextrin–rhEGF conjugates as bioresponsive nanomedicines for wound repair

(2008) J HARDWICKE et al.   JOURNAL OF CONTROLLED RELEASE